Publications by the researcher in collaboration with Iván Alejandro Ferraz Amaro (63)

2024

  1. Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease

    Antioxidants, Vol. 13, Núm. 10

  2. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

  3. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

    European Journal of Internal Medicine, Vol. 129, pp. 78-86

  4. Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature

    Arthritis Research and Therapy, Vol. 26, Núm. 1

  5. Interleukin-6 serum levels are associated with disease features and cardiovascular risk in patients with systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 42, Núm. 8, pp. 1564-1570

  6. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  7. Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus

    Life, Vol. 14, Núm. 4

  8. Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis

    Journal of Rheumatology

  9. Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 42, Núm. 9, pp. 1773-1780

  10. Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis

    Frontiers in Immunology, Vol. 15

  11. Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 12, Núm. 5

  12. Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients

    RMD open, Vol. 10, Núm. 2

  13. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients

    Seminars in Arthritis and Rheumatism, Vol. 68

  14. The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 26, Núm. 1

  15. The complement system is linked to insulin resistance in patients with systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121

  16. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

    RMD open, Vol. 10, Núm. 2

2023

  1. Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis

    European Journal of Internal Medicine

  2. Alpha-Klotho protein in systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 41-47

  3. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

  4. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10